Yanan Bicon Pharmaceutical Listed Company’s Net Profit Dropped 46% in First Three Quarters of 2022

Yanan Bicon Pharmaceutical Listed Company (延安必康制药股份有限公司) (002411.SZ) reported a net profit of 379.8 million yuan in the first three quarters of 2022, down 46% year-on-year.

Meanwhile, the company posted 6.2 billion yuan in revenue, up 10.4% year-on-year.

At the end of the reporting period, it had 18.2 billion yuan in total assets and 9.7 billion yuan in total liabilities, with a liability-to-asset ratio of 53.4%.